期刊文献+

多重耐药铜绿假单胞菌氨基糖苷类修饰酶基因研究 被引量:3

Study of aminoglycosides modification gene in multidrug-resistant Pseudomonas aeruginosa
原文传递
导出
摘要 目的:了解铜绿假单胞菌氨基糖苷类修饰酶基因存在情况,为耐药性监测提供依据。方法:采用VITEK-32配套GNS-448及K-B法测定铜绿假单胞菌对抗菌药物的敏感性,采用聚合酶链反应及序列分析的方法分析氨基糖苷类修饰酶基因类型。结果:20株多重耐药铜绿假单胞菌对亚胺培南、美洛培南全部耐药,哌拉西林/他唑巴坦、头孢吡肟及头孢他啶的耐药率分别为90.0%、100%和85%,氨基糖苷类抗生素的耐药率为阿米卡星85.0%、庆大霉素100%,对其他抗菌药物的耐药率均在85.0%以上。20株铜绿假单胞菌中检出5株aac(6)′-Ⅰb、1株aac(6)′-Ⅱ、15株ant(3)′-Ⅰ、8株ant(2)′-Ⅰ,阳性率分别为25%、5%、75.0%、40%。其他基因型阴性。结论:本院重症监护病房临床分离的铜绿假单胞菌多重耐药严重,氨基糖苷类修饰酶基因携带率较高。 Objective:To get a general idea about the existence of the aminoglycosides modification gene in multidrug-resistant Pseudomonas aeruginosa strains collected from the patients in ICU(intensive care unit) and give the theory supporting of the drug resistance monitoring.Methods:Using VITEK-32 matched with GNS-448 and KB method to detect the sensitivities of Pseudomonas aeruginosa strains to the antibiotics,adopting polymerase chain reaction and sequence analysis methods to typing the aminoglycosides modification genes.Results:Among the 20 Multidrug-Resistant Pseudomonas aeruginosa strains being detected,there were 100.0% of them resistant to Imipenem and Meroperem;90.0% to Piperacillin /Tazobactam;100% to Cefepime;85.0% to Ceftazidime;85.0% to Amikacin,100% to Cidomycin in aminoglycoside antibiotics;above 85.0% to other antibiotics.aac(6′)-Ⅰb was found in 5 strains,possessing 25% positive ratio;aac(6′)-Ⅱin 1,5%;ant(3′)-Ⅰin 15,75.0%;ant(2′)-Ⅰin 8,40%.Other genetypes were not found.Conclusion:Pseudomonas aeruginosa strains are multidrug-resistant seriously,taking aminoglycosides modification gene with a high proportion in ICU of our hospital.
出处 《中国卫生检验杂志》 CAS 2010年第1期105-106,共2页 Chinese Journal of Health Laboratory Technology
关键词 铜绿假单胞菌 抗药性 氨基糖苷类修饰酶基因 聚合酶链反应 Pseudomonas aeruginosa Drug resistance Aminoglycosides modification gene Polymerase chain reaction
  • 相关文献

参考文献5

二级参考文献40

  • 1蒋晓飞,倪语星.铜绿假单胞菌产生的超广谱β-内酰胺酶[J].中华微生物学和免疫学杂志,2001,21(S1):10-12. 被引量:10
  • 2糜祖煌.铜绿假单胞菌耐药基因及其检测[J].现代实用医学,2004,16(9):558-560. 被引量:47
  • 3金正江,彭少华,李从荣.铜绿假单胞菌主动外排系统MexAB-OprM与耐药的关系研究[J].中华医院感染学杂志,2004,14(8):841-843. 被引量:30
  • 4NCCLS. Performance standards for antimicrobial susceptibility testing[S]. Fourteenth informational supplement. NCCLS, 2004.24(1):102-103.
  • 5Galimand M,Gerbaud G,Courvalin P.Spectinomycin resistance in Neisseria spp.due to mutations in 16S rRNA[J]. Antimicrob Agents Chemother,2000,44(5):1365-1366.
  • 6Patzer J,Toleman MA, Deshpande LM, et al. Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J Antimicrob Chemother,2004 ,53:451-456.
  • 7Poirel L, Lebessi E, Castro M, et al. Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece. Antimicrob Agents Chemother,2004,48:2277-2279.
  • 8Girlich D, Naas T, Nordmann P. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob Agents Chemother, 2004,48:2043-2048.
  • 9Pagani L, Mantengoli E, Migliaracca R,et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy. J Clin Microbiol,2004 ,42:2523-2529.
  • 10Weldhagen GF, Prinsloo A. Molecular detection of GES-2 extended spectrum beta-Lactamase producing Pseudomonas aeruginosa in Pretoria, South Africa. Int J Antimicrob Agents,2004 ,24:35-38.

共引文献111

同被引文献20

  • 1植志全,江鹏,何志恒,邹惠锋,马劲光.医院感染肺炎克雷伯菌耐药性及氨基糖苷类修饰酶、β-内酰胺酶基因研究[J].中华医院感染学杂志,2005,15(11):1208-1213. 被引量:15
  • 2Tomás M,Doumith M,Warner M,et al.Efflux pumps,OprD porin,AmpC beta-lactamase,and multiresistance inPseudomonas aeruginosaisolates from cystic fibrosis patients[J].Antimicrob Agents Chemother,2010,54(5):2219-2224.
  • 3Vettoretti L,Floret N,Hocquet D,et al.Emergence of ex-tensive-drug-resistant Pseudomonas aeruginosain a French u-niversity hospital[J].Eur J Clin Microbiol Infect Dis,2009,28(10):1217-1222.
  • 4Gootz TD,Marra A.Acinetobacter baumannii:an emergingmultidrug-resistant threat[J].Expert Rev Anti Infect Ther,2008,6(3):309-325.
  • 5Cholley P,Gbaguidi-Haore H,Bertrand X,et al.Molecularepidemiology of multidrug-resistant Pseudomonas aeruginosain a French university hospital[J].J Hosp Infect,2010,76(4):316-319.
  • 6Moya B,Zamorano L,Juan C,et al.Activity of a new cepha-losporin,CXA-101(FR264205),against beta-lactam-resist-ant Pseudomonas aeruginosa mutants selected in vitro and af-ter antipseudomonal treatment of intensive care unit patients[J].Antimicrob Agents Chemother,2010,54(3):1213-1217.
  • 7Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes [ J ]. Drug Resist Update, 2010, 13(6) :151 -171.
  • 8Dubois V, Poirel L, Marie C, et al. Moleeular characterization of a novel class 1 integron containing bla( GES - 1) and a fused Product of aac (3) -Ib and aac (6') -Ib gene Cassettes in Pseudomonas aerugi- nosa[ J]. Antimicrob Agents Chemother, 2002, 46 (3) :638 - 645.
  • 9王伟,糜祖煌,毛剑锋,徐伟珍.大肠埃希菌连续分离株氨基糖苷类修饰酶aac(6')-Ⅰb基因分型研究[J].中国人兽共患病学报,2008,24(5):486-486. 被引量:12
  • 10张雪青,陈增强,陈俐丽,余方友.大肠埃希菌临床分离株aac(6)′-Ib-cr基因的检测[J].中国卫生检验杂志,2008,18(7):1266-1268. 被引量:5

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部